Loading...
Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF•PNK
Healthcare
Medical - Pharmaceuticals
$0.65
$0.00(0.00%)
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Financial Performance & Income Statement Overview
Review Beijing Tong Ren Tang Chinese Medicine Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
725.25%
↑ 725.25%
Operating Income Growth
621.77%
↑ 621.77%
Net Income Growth
-88.09%
↓ 88.09%
Operating Cash Flow Growth
-468.22%
↓ 468.22%
Operating Margin
39.78%
↑ 39.78%
Gross Margin
70.73%
↑ 70.73%
Net Profit Margin
34.98%
↑ 34.98%
ROE
3.30%
↑ 3.30%
ROIC
1.20%
↑ 1.20%
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Income Statement & Financial Overview
Review Beijing Tong Ren Tang Chinese Medicine Company Limited's (BJTRF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $473.56M | $473.56M | $42.55M | $42.46M |
| Cost of Revenue | $166.78M | $166.78M | $13.62M | $13.59M |
| Gross Profit | $306.78M | $306.78M | $28.93M | $28.87M |
| Gross Profit Ratio | $0.65 | $0.65 | $0.68 | $0.68 |
| R&D Expenses | $4.56M | $4.56M | $0.00 | $0.00 |
| SG&A Expenses | $148.58M | $148.58M | $12.60M | $12.57M |
| Operating Expenses | $147.76M | $147.76M | $12.35M | $12.32M |
| Total Costs & Expenses | $314.54M | $314.54M | $25.97M | $25.92M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.17M | $4.65M | $595785.00 | $594532.00 |
| EBITDA | $161.76M | $162.24M | $17.17M | $17.14M |
| EBITDA Ratio | $0.34 | $0.34 | $0.40 | $0.40 |
| Operating Income | $159.02M | $159.02M | $16.58M | $16.54M |
| Operating Income Ratio | $0.34 | $0.34 | $0.39 | $0.39 |
| Other Income/Expenses (Net) | $14.04M | $14.04M | $1.59M | $1.58M |
| Income Before Tax | $173.07M | $173.07M | $18.16M | $18.12M |
| Income Before Tax Ratio | $0.37 | $0.37 | $0.43 | $0.43 |
| Income Tax Expense | $28.65M | $28.65M | $2.77M | $2.77M |
| Net Income | $140.25M | $140.25M | $14.07M | $14.04M |
| Net Income Ratio | $0.30 | $0.30 | $0.33 | $0.33 |
| EPS | $0.17 | $0.17 | $0.02 | $0.02 |
| Diluted EPS | $0.17 | $0.17 | $0.02 | $0.02 |
| Weighted Avg Shares Outstanding | $837.10M | $837.10M | $837.11M | $837.11M |
| Weighted Avg Shares Outstanding (Diluted) | $837.10M | $837.10M | $837.10M | $837.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan